BANGALORE --Dabur India Ltd. has entered into an agreement with Mumbai-based Ajanta Pharma Ltd. to acquire its over-the-counter '30-Plus' brand for an undisclosed amount.

"The acquisition of 30-Plus is part of an aggressive strategy to build capability on the over-the-counter health care business," said Dabur Group Director P.D. Narang in a statement.

The consumer-goods maker didn't provide any financial details.

30-Plus is a herbal capsule positioned as an energizing capsule for men above the age of thirty.

PricewaterhouseCoopers was the adviser to the deal, the statement said.